Marlys Hammond

1.1k total citations
24 papers, 778 citations indexed

About

Marlys Hammond is a scholar working on Organic Chemistry, Molecular Biology and Genetics. According to data from OpenAlex, Marlys Hammond has authored 24 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 12 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Marlys Hammond's work include Chemical Synthesis and Analysis (6 papers), Chemical synthesis and alkaloids (6 papers) and Estrogen and related hormone effects (4 papers). Marlys Hammond is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Chemical synthesis and alkaloids (6 papers) and Estrogen and related hormone effects (4 papers). Marlys Hammond collaborates with scholars based in United States and United Kingdom. Marlys Hammond's co-authors include Andrew G. Myers, Yusheng Wu, Stephen W. Kaldor, Jeffrey Aubé, Philip M. Harrington, Elaine Y. Kuo, Jaclyn R. Patterson, Scott K. Thompson, Walter Trizna and Nicholas J. Laping and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Marlys Hammond

24 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marlys Hammond United States 15 426 384 67 54 53 24 778
Robert Aslanian United States 23 756 1.8× 623 1.6× 109 1.6× 72 1.3× 59 1.1× 83 1.4k
James Dowden United Kingdom 18 418 1.0× 437 1.1× 21 0.3× 65 1.2× 20 0.4× 34 1.0k
Bernhard Kutscher Germany 16 284 0.7× 572 1.5× 71 1.1× 64 1.2× 201 3.8× 49 905
Kevin N. Dack United Kingdom 12 221 0.5× 260 0.7× 114 1.7× 99 1.8× 34 0.6× 22 683
Toshihiro Hatanaka Japan 11 529 1.2× 413 1.1× 89 1.3× 98 1.8× 14 0.3× 17 1.0k
Hazel J. Dyke United Kingdom 20 382 0.9× 468 1.2× 170 2.5× 34 0.6× 64 1.2× 30 911
Gary A. Flynn United States 19 441 1.0× 653 1.7× 31 0.5× 128 2.4× 112 2.1× 51 1.1k
John J. Piwinski United States 21 565 1.3× 538 1.4× 122 1.8× 90 1.7× 113 2.1× 49 1.1k
Katsutoshi Yamada Japan 11 311 0.7× 502 1.3× 121 1.8× 46 0.9× 27 0.5× 20 1.0k
Markus Pietsch Germany 20 348 0.8× 461 1.2× 145 2.2× 68 1.3× 78 1.5× 53 982

Countries citing papers authored by Marlys Hammond

Since Specialization
Citations

This map shows the geographic impact of Marlys Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlys Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlys Hammond more than expected).

Fields of papers citing papers by Marlys Hammond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlys Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlys Hammond. The network helps show where Marlys Hammond may publish in the future.

Co-authorship network of co-authors of Marlys Hammond

This figure shows the co-authorship network connecting the top 25 collaborators of Marlys Hammond. A scholar is included among the top collaborators of Marlys Hammond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlys Hammond. Marlys Hammond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Behm, David J., Hilary S. Eidam, Marlys Hammond, et al.. (2019). Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4). ACS Medicinal Chemistry Letters. 10(8). 1228–1233. 36 indexed citations
2.
Wang, Yonghui, Chaya Duraiswami, Kevin P. Madauss, et al.. (2009). 2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2′,3′:4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonists. Bioorganic & Medicinal Chemistry Letters. 19(17). 4916–4919. 11 indexed citations
3.
Dow, Robert L., John R. Hadcock, Dennis O. Scott, et al.. (2009). Bioisosteric replacement of the hydrazide pharmacophore of the cannabinoid-1 receptor antagonist SR141716A. Part I: Potent, orally-active 1,4-disubstituted imidazoles. Bioorganic & Medicinal Chemistry Letters. 19(18). 5351–5354. 11 indexed citations
4.
Washburn, David G., Tram H. Hoang, James S. Frazee, et al.. (2009). Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists. Bioorganic & Medicinal Chemistry Letters. 19(16). 4664–4668. 7 indexed citations
5.
Hammond, Marlys, Jaclyn R. Patterson, Tram H. Hoang, et al.. (2009). Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonists. Bioorganic & Medicinal Chemistry Letters. 19(10). 2637–2641. 10 indexed citations
6.
Hammond, Marlys, David G. Washburn, Tram H. Hoang, et al.. (2009). Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(15). 4441–4445. 37 indexed citations
7.
Sherk, Andrea B., Daniel E. Frigo, Christine G. Schnackenberg, et al.. (2008). Development of a Small-Molecule Serum- and Glucocorticoid-Regulated Kinase-1 Antagonist and Its Evaluation as a Prostate Cancer Therapeutic. Cancer Research. 68(18). 7475–7483. 174 indexed citations
8.
Elliott, Richard L., Robert M. Oliver, Marlys Hammond, et al.. (2003). Structure–activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(20). 3593–3596. 24 indexed citations
9.
Hammond, Marlys, Richard L. Elliott, David C. Hager, et al.. (2003). Structure–activity relationships in a series of NPY Y5 antagonists: 3-amido-9-ethylcarbazoles, core-modified analogues and amide isosteres. Bioorganic & Medicinal Chemistry Letters. 13(12). 1989–1992. 10 indexed citations
10.
Myers, Andrew G., Ralf Glatthar, Marlys Hammond, et al.. (2002). Development of an Enantioselective Synthetic Route to Neocarzinostatin Chromophore and Its Use for Multiple Radioisotopic Incorporation. Journal of the American Chemical Society. 124(19). 5380–5401. 60 indexed citations
11.
Myers, Andrew G., Jun Liang, Marlys Hammond, et al.. (1998). Total Synthesis of (+)-Neocarzinostatin Chromophore. Journal of the American Chemical Society. 120(21). 5319–5320. 50 indexed citations
12.
Myers, Andrew G., Michael E. Kort, & Marlys Hammond. (1997). A Comparison of DNA Cleavage by Neocarzinostatin Chromophore and Its Aglycon:  Evaluating the Role of the Carbohydrate Residue. Journal of the American Chemical Society. 119(13). 2965–2972. 32 indexed citations
13.
Myers, Andrew G., et al.. (1996). A concise synthesis of the naphthoic acid component of neocarzinostatin chromophore featuring a new photocyclization reaction. Tetrahedron Letters. 37(5). 587–590. 13 indexed citations
14.
Myers, Andrew G., Marlys Hammond, & Yusheng Wu. (1996). An improved preparation of highly enantiomerically enriched (R)-(+)-4-tert-butyldimethylsiloxy-2-cyclopenten-1-one. Tetrahedron Letters. 37(18). 3083–3086. 34 indexed citations
15.
Kaldor, Stephen W., Krzysztof Appelt, James E. Fritz, et al.. (1995). A systematic study of P1–P3 spanning sidechains for the inhibition of HIV-1 protease. Bioorganic & Medicinal Chemistry Letters. 5(7). 715–720. 7 indexed citations
16.
Kaldor, Stephen W., et al.. (1995). Glutamine-derived aldehydes for the inhibition of human rhinovirus 3C protease. Bioorganic & Medicinal Chemistry Letters. 5(17). 2021–2026. 34 indexed citations
17.
Kaldor, Stephen W., Bruce A. Dressman, Marlys Hammond, et al.. (1995). Isophthalic acid derivatives: amino acid surrogates for the inhibition of HIV-1 protease. Bioorganic & Medicinal Chemistry Letters. 5(7). 721–726. 13 indexed citations
18.
Kaldor, Stephen W. & Marlys Hammond. (1991). A mild, osmium tetraoxide-catalyzed method for the oxidation of sulfides to sulfones. Tetrahedron Letters. 32(38). 5043–5046. 48 indexed citations
19.
Aubé, Jeffrey & Marlys Hammond. (1990). Directed regiochemical control in the ring expansion reactions of a substituted trans-decalone. Tetrahedron Letters. 31(21). 2963–2966. 27 indexed citations
20.
Aubé, Jeffrey, et al.. (1990). Synthetic aspects of an asymmetric nitrogen-insertion process: preparation of chiral, non-racemic caprolactams and valerolactams. Total synthesis of (-)-alloyohimbane. Journal of the American Chemical Society. 112(12). 4879–4891. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Aslanian Breakdown of academic impact, for papers by James Dowden Breakdown of academic impact, for papers by Bernhard Kutscher Breakdown of academic impact, for papers by Kevin N. Dack Breakdown of academic impact, for papers by Toshihiro Hatanaka Breakdown of academic impact, for papers by Hazel J. Dyke Breakdown of academic impact, for papers by Gary A. Flynn Breakdown of academic impact, for papers by John J. Piwinski Breakdown of academic impact, for papers by Katsutoshi Yamada Breakdown of academic impact, for papers by Markus Pietsch
Rankless by CCL
2026